Lung injury linked to etanercept therapy
- PMID: 12426295
- DOI: 10.1378/chest.122.5.1858
Lung injury linked to etanercept therapy
Abstract
Etanercept is the first anticytokine drug approved to treat rheumatoid arthritis. Side effects are infrequent, the most common being local skin reactions, headaches, and upper respiratory tract symptoms. We report the first case of lung injury that occurred while receiving this agent. Biopsy specimens of lung and skin lesions demonstrated noncaseating granulomas associated with a microscopic particulate. Withdrawal of etanercept achieved clinical stabilization, and the addition of prednisone resulted in rapid improvement.
Comment in
-
Etanercept or mycobacterium lung injury?Chest. 2003 Sep;124(3):1174; author reply 1174-5. doi: 10.1378/chest.124.3.1174. Chest. 2003. PMID: 12970055 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
